News
Identified a gene responsible for a genetic disorder of myelin
In the study, published and selected as a featured article in the journal Cell Group The American Journal of Human Genetics, also have participated Albert Martinez, researcher at Institute for Research in Biomedicine (IRB Barcelona) and Virginia Nunes, professor at UB and IDIBELL researcher. More information: http://www.ub.edu/web/ub/ca/menu_eines/noticies/2011/05/009.html
Proposed new strategies for treatment of cardiovascular disease in diabetics
U p to 40% of patients with diabetes do not respond to usual treatments A review article realized by researchers at IDIBELLabout the situation of antiplatelet therapy in acute coronary syndromes in patients with type 2 diabetes highlights the need for new potent therapies for this population at risk. Response to current drugs Article’s reference
Agreement between IDIBELL and Vicente Ferrer Foundation to develop research activities
IDIBELL and Vicente Ferrer Foundation have signed a cooperation agreement to conduct common research activities. The framework agreement includes the exchange of research staff, organization of scientific events, the development of innovative health interventions and technology transfer activities, and the use of scientific facilities. The agreement includes a program to support predoctoral biomedicine students from India hosted by Vicente Ferrer Foundation in Andhra Pradesh region of India. The programme offers the possibility to obtain the PhD degree at IDIBELL facilities.
Discovered a new mechanism which protects the genome under conditions of oxidative stress
Oxidative stress causes genomic instability and it could be involved in cancer emergence The role of sirtuins Article’s reference
Molecule Nutlin-3a activates a signal inducing cell death and senescence in primary brain tumors
IDIBELL researchers at UB have tested this molecule antagonist of MDM2, a protein active in brain tumors New therapeutic targets Article reference
Henning Walczak: ”We have all the mechanisms at our disposal to know the enemy and fight it”
The Walczak research group aims at understanding how the immune system specifically attacks the cancer and to uncover the mechanisms used by tumors to counteract these attacks. The researcher has explained his research in the TRAIL signaling pathway (TNF– related apoptosis-inducing ligand) to discover new therapeutic targets that can be combined with other drugs causing […]